Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$261M |
| 2 |
Alibaba
BABA
|
+$233M |
| 3 |
Truist Financial
TFC
|
+$191M |
| 4 |
Microsoft
MSFT
|
+$160M |
| 5 |
Amazon
AMZN
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$415M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$186M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$73.8M |
| 4 |
Oracle
ORCL
|
+$25.8M |
| 5 |
CBLK
Carbon Black, Inc. Common Stock
CBLK
|
+$23.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 15.12% |
| 3 | Healthcare | 12.68% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Communication Services | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APHA
2251
DELISTED
Aphria Inc. Common Shares
APHA
| $418K | ﹤0.01% |
79,961
| – | – |
|
|
JKS
2252
JinkoSolar
JKS
$855M
| $417K | ﹤0.01% |
18,542
+15,486
| +507% | +$270K |
|
|
ZEUS
2253
DELISTED
Olympic Steel
ZEUS
| $416K | ﹤0.01% |
23,214
+1,199
| +5% | +$19.1K |
|
2254
Weis Markets
WMK
$1.87B
| $414K | ﹤0.01% |
10,233
| – | – |
|
2255
Barnes & Noble Education
BNED
$438M
| $412K | ﹤0.01% |
964
+76
| +9% | +$31.2K |
|
|
MODN
2256
DELISTED
MODEL N, INC.
MODN
| $411K | ﹤0.01% |
11,718
+1,495
| +15% | +$45.5K |
|
2257
Northern Oil and Gas
NOG
$2.19B
| $409K | ﹤0.01% |
17,469
| – | – |
|
|
MDR
2258
DELISTED
McDermott International
MDR
| $409K | ﹤0.01% |
604,375
+35,580
| +6% | +$45.5K |
|
2259
Liquidity Services
LQDT
$1.33B
| $406K | ﹤0.01% |
68,166
+2,951
| +5% | +$19K |
|
2260
Lakeland Financial Corp
LKFN
$1.57B
| $404K | ﹤0.01% |
8,258
+718
| +10% | +$33.4K |
|
2261
Veracyte
VCYT
$3.63B
| $404K | ﹤0.01% |
14,467
+4,316
| +43% | +$112K |
|
2262
Virtu Financial
VIRT
$4.97B
| $401K | ﹤0.01% |
25,120
+797
| +3% | +$13.1K |
|
2263
Sprout Social
SPT
$493M
| $400K | ﹤0.01% |
+24,700
| New | +$401K |
|
|
HAPN
2264
Happen Inc
HAPN
$2.35B
| $397K | ﹤0.01% |
31,429
| – | – |
|
2265
Opko Health
OPK
$1B
| $397K | ﹤0.01% |
270,418
+3,922
| +1% | +$6.57K |
|
|
CCXI
2266
DELISTED
ChemoCentryx, Inc.
CCXI
| $394K | ﹤0.01% |
9,961
+1,603
| +19% | +$28.1K |
|
|
TPTX
2267
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $394K | ﹤0.01% |
6,339
+5,233
| +473% | +$249K |
|
|
DRNA
2268
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $392K | ﹤0.01% |
17,808
+4,142
| +30% | +$83.4K |
|
2269
Middlesex Water
MSEX
$1.1B
| $391K | ﹤0.01% |
6,150
+744
| +14% | +$47.1K |
|
2270
Ingles Markets
IMKTA
$1.65B
| $389K | ﹤0.01% |
8,183
+4,160
| +103% | +$177K |
|
2271
Cactus
WHD
$5.43B
| $387K | ﹤0.01% |
11,272
+1,837
| +19% | +$55.8K |
|
2272
AtriCure
ATRC
$2.02B
| $386K | ﹤0.01% |
11,856
+1,709
| +17% | +$48.6K |
|
2273
First Interstate BancSystem
FIBK
$3.64B
| $386K | ﹤0.01% |
9,213
| – | – |
|
2274
Nordic American Tanker
NAT
$1.36B
| $385K | ﹤0.01% |
78,352
+51,327
| +190% | +$196K |
|
2275
Ring Energy
REI
$320M
| $383K | ﹤0.01% |
146,107
+4,879
| +3% | +$9.57K |
|
Similar funds
Legal & General Group's Q4 2019 Portfolio in Review
As of Q4 2019, Legal & General Group held 3,425 positions worth $210B, up 11% from $190B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3.9%. Legal & General Group opened 77 new positions and exited 57, leaving the 3,425-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- Legal & General Group's largest Q4 2019 buy was iShares MSCI Emerging Markets ETF: 425,000 shares worth $19.1M.
- Legal & General Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $261M increase.
- Legal & General Group's biggest Q4 2019 reduction was Oracle, cutting an estimated $25.8M.
- Legal & General Group fully exited Celgene Corp in Q4 2019, selling an estimated $415M.
- Legal & General Group's ten largest holdings make up 18% of its $210B portfolio in Q4 2019.
- Legal & General Group opened 77 new positions and closed 57 in Q4 2019.
- Legal & General Group's portfolio value rose 11% quarter-over-quarter to $210B.
Based on Legal & General Group's 13F filing for Q4 2019, filed 13 Feb 2020.